We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The Home Secretary has accepted the ACMD’s recommendation to reclassify methylamphetamine to a Class A Drug. Methylamphetamine (commonly referred…
A review of MDMA (‘ecstasy’), its harms and classification under the Misuse of Drugs Act 1971 (2009). The Advisory Council on the Misuse of…
ACMD have issued a response to government priorities.
ACMD recommendations regarding gamma-butyrolactone (GBL) and 1,4-BD. Date: Wed Aug 06 16:27:07 BST 2008 Full Document ACMD report on gamma…
The Advisory Council on the Misuse of Drugs has undertaken a review of naloxone's availability.
Information on the introduction of the Welsh programme of take-home naloxone.
Hidden Harm Three Years On: ACMD Press Release
ACMD advice on prescribing by Allied Health Professions, February 2013
Public invitation to an evidence gathering meeting on 21 September 2016.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).